Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

F. Di Filippo, A. Calabro, D. Giannarelli, S. Carlini, F. Cavaliere, F. Moscarelli, R. Cavaliere

Research output: Contribution to journalArticle

Abstract

Between October 1969 and December 1986, 136 patients with recurrent limb melanoma were treated with hyperthermic antiblastic perfusion (HAP). This retrospective analysis is aimed at identifying tumor-related and treatment-related variables likely to influence tumor response, locoregional control, disease-free survival, and overall survival. Independent factors predicting a complete response (CR) were the number of lesions (P

Original languageEnglish
Pages (from-to)2551-2561
Number of pages11
JournalCancer
Volume63
Issue number12
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion'. Together they form a unique fingerprint.

  • Cite this

    Di Filippo, F., Calabro, A., Giannarelli, D., Carlini, S., Cavaliere, F., Moscarelli, F., & Cavaliere, R. (1989). Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer, 63(12), 2551-2561.